A randomized, double-blind, placebo-controlled, multicenter phase III trial to investigate the efficacy and safety of ganaxolone in adults with focal onset seizures

Trial Profile

A randomized, double-blind, placebo-controlled, multicenter phase III trial to investigate the efficacy and safety of ganaxolone in adults with focal onset seizures

Planning
Phase of Trial: Phase III

Latest Information Update: 11 Sep 2015

At a glance

  • Drugs Ganaxolone (Primary)
  • Indications Epilepsy; Seizures
  • Focus Registrational; Therapeutic Use
  • Sponsors Marinus Pharmaceuticals
  • Most Recent Events

    • 11 Sep 2015 New trial record
    • 09 Sep 2015 This trial is expected to begin in 2016, according to a Marinus Pharmaceuticals media release. The company plans to submit the protocol of this trial to the FDA for a special protocol assessment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top